Nippon Chemiphar Successfully Reverses Decline
Annual Results See Company Make Up Shortfall From Earlier In The Year
Japan’s Nippon Chemiphar gets a grip on a decline in pharmaceutical sales seen earlier this year, on the back of strong sales of generic drugs launched last year. The company also expects an upward impact from expanded sales of generic drugs achieved through sales channel diversification efforts for its current financial year ending 31 March 2022.
